Lin-hua H. Yang
No. 382, WuYi Rd
Taiyuan, 030001, China
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Analysis of Emerging Gene Variant and Molecular Mechanism Study of a Patient with Inherited FXI Deficiency
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
Analysis of VWF Gene c.7332G>A Nonsense Mutation Pedigree and Study of Molecular Pathogenesis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026
Analysis of Influencing Factors and Establishment of Nomogram Model of Differentiation Syndrome in Patients with Acute Promyelocytic Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: February 28, 2025
The Clinical Phenotype and Molecular Pathogenic Mechanism of a Family with Hereditary Coagulation Factor V Deficiency
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 01, 2025
Phylogenetic analysis and pathogenesis study of a new deletion mutation causing inherited FⅩ deficiency
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 02, 2024
Pedigree Analysis and Molecular Mechanism Study of Hereditary Glanzmann Thrombasthenia Caused by Compound Heterozygous Mutation of the ITGA2B Gene
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: July 01, 2024
Prognostic Value of Prothrombin Time and Activated Partial Thromboplastin Time in Newly Diagnosed Patients with Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 27, 2024
Genetic characteristics and clinical analysis of 20 patients with Gaucher's disease
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 25, 2024
Short-term Effect of Venetoclax Combined with Azacitidine and "7+3" Regimen in the Treatment of Newly Diagnosed Elder Patients with Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: February 22, 2024
Clinical characteristics and prognostic implications of RAS mutations in newly diagnosed acute myeloid leukemia with normal karyotype based on next-generation sequencing analysis
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 04, 2023
Advances in molecular targeted therapies of chronic lymphocytic leukemia
Journal: Zhonghua nei ke za zhi
Published: December 03, 2023
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
Journal: Journal of cancer research and clinical oncology
Published: September 28, 2023
Last Updated: 09/26/2026